Assignee
BLISS BIOPHARMACEUTICAL HANGZHOU CO LTD
CN·2 granted patents·4 pending applications·1 citations·filing 2020–2024
Top patents by PatentIndex Score
6 records- 0179US10994021B1Tetravalent antibody-drug conjugates and use thereofBLISS BIOPHARMACEUTICAL HANGZHOU CO LTD·Filed 2020·Granted May 4, 2021·1 cites·15 claims
- 0274US2024342304A1Tetravalent Antibody-Drug Conjugates and Use ThereofBLISS BIOPHARMACEUTICAL HANGZHOU CO LTD·Filed 2024·Application pending·0 cites
- 0367US11951173B2Tetravalent antibody-drug conjugates and use thereofBLISS BIOPHARMACEUTICAL HANGZHOU CO LTD·Filed 2021·Granted Apr 9, 2024·0 cites·13 claims
- 0465US2024002527A1Anti-cd73 antibody, antibody-drug conjugate, and use thereofBLISS BIOPHARMACEUTICAL HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0565US2024075154A1Engineered antibody, antibody-drug conjugate, and use thereofBLISS BIOPHARMACEUTICAL HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0665US2023414781A1Anti-cd276 antibody, antibody-drug conjugate, and use thereofBLISS BIOPHARMACEUTICAL HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BLISS BIOPHARMACEUTICAL HANGZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →